Nemluvio

Active Ingredient(s): Nemolizumab-ilto
FDA Approved: * August 12, 2024
Pharm Company: * GALDERMA LABS LP
Category: Skin Care
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Nemluvio 30 mg/100mg Subcutaneous Injection, Powder, Lyophilized, for Solution
NDC: 0299-6220
Labeler:
Galderma Laboratories, L.p.